Pronova’s new plant doubles capacity for its omega-3 product

Pronova BioPharma ASA of Norway has doubled the production capacity for omega-3-acid ethyl esters, the active pharmaceutical ingredient of Omacor, its prescription medicine for heart disease, with the opening of a new plant in Denmark.